Safety of Manuka honey CycloPower ophthalmic cream

Not Applicable

Completed

• Conditions: Blepharitis; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12616000540415
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1. Male or female healthy subjects aged 18-45 and in good health as determined by past medical history, physical examination, vital signs at screening.
2. Subjects must be able to communicate well with the investigator, to understand and comply with the requirements of the study and understand and sign the written informed consent.
3. Be willing not to wear contact lenses for 2 days prior to the start of the study and for the duration of the study

Exclusion Criteria

1. Known allergy to any components of the microemulsion (bee products or Manuka honey Cyclopower)
2. Pregnancy or planned pregnancy during the course of the study
3. A past medical history or evidence of significant dermatological conditions e.g. eczema, dermatitis
4. A past medical history or evidence of ophthalmic disease that could affect study outcomes
5. A past history or evidence of systemic disease that could affect the study outcomes
6. Dosing of a study drug in any clinical investigation within 30 days prior to initial treatment in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified